Barriers to medication entitlements after diagnosis of ADHD - Authors' reply
Sayal, Kapil Prasad, Vibhore Daley, David
Sayal, Kapil
Prasad, Vibhore
Daley, David
Abstract
We thank John Hayden and colleagues for their helpful comments on our paper. We are also pleased that a resolution was found in Ireland for the particular problem that had been limiting access to care for those with attention-deficit hyperactivity disorder (ADHD). We agree that it is important to consider and address barriers to care that might exist post-diagnosis and thank them for highlighting this issue. There is considerable variation in the way that reimbursement for medications is handled within different health-care systems as well as disparity in how rules are applied for different disorders.
MIDER Authors
Citations
Altmetric:
Date
2018
Type
Commentary
Subject
Attention deficit disorder with hyperactivity, Diagnosis
Collections
Citation
Sayal, K., Prasad, V., Daley, D., Ford, T. & Coghill, D. (2018). Barriers to medication entitlements after diagnosis of ADHD - Authors' reply. The Lancet Psychiatry, 5 (1), pp.19-20.